Q1 2026 Holdings
Filed 2026-05-14 | 83 holdings | $249.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr Series Trust(XBI)Call | STATE STREET SPD | 78464A870 | $51.1M | 400,000 | 20.5% |
| Spdr Series Trust(XBI)Put | STATE STREET SPD | 78464A870 | $51.1M | 400,000 | 20.5% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $17.5M | 3,302,300 | 7.0% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $15.6M | 975,200 | 6.2% |
| Adma Biologics Inc(ADMA)Call | COM | 000899104 | $10.4M | 1,150,000 | 4.1% |
| Evolus Inc(EOLS) | COM | 30052C107 | $7.2M | 1,759,091 | 2.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $6.7M | 740,000 | 2.7% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $6.1M | 1,389,622 | 2.5% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $6.1M | 85,000 | 2.4% |
| Terns Pharmaceuticals Inc(TERN)Call | COM | 880881107 | $5.3M | 100,000 | 2.1% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $4.5M | 480,000 | 1.8% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.6M | 383,462 | 1.4% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $3.3M | 746,587 | 1.3% |
| Establishment Labs Hldgs Inc(ESTA)Call | COM | G31249108 | $2.8M | 50,000 | 1.1% |
| Kazia Therapeutics LTD | SPONSORED ADS | 48669G303 | $2.6M | 345,179 | 1.0% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $2.4M | 713,845 | 1.0% |
| Alexandria Real Estate EQ in(ARE)Call | COM | 015271109 | $2.3M | 50,000 | 0.9% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $2.2M | 100,000 | 0.9% |
| Sol-Gel Technologies LTD(SLGL) | SHS NEW | M8694L137 | $2.2M | 27,778 | 0.9% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $2.2M | 69,500 | 0.9% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $2.2M | 792,289 | 0.9% |
| Curis Inc(CRIS) | COM | 231269309 | $2.0M | 3,726,406 | 0.8% |
| Evolus Inc(EOLS)Call | COM | 30052C107 | $1.7M | 420,000 | 0.7% |
| Xeris Biopharma Holdings Inc(XERS)Call | COM | 98422E103 | $1.6M | 280,000 | 0.7% |
| Tela BIO Inc(TELA) | COM | 872381108 | $1.6M | 2,617,252 | 0.6% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $1.6M | 957,202 | 0.6% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $1.6M | 85,000 | 0.6% |
| Adicet BIO Inc(ACET) | COM NEW | 007002207 | $1.5M | 221,955 | 0.6% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $1.4M | 335,309 | 0.6% |
| Okyo Pharma LTD | SHS NEW | G6724L116 | $1.4M | 850,000 | 0.5% |
| SI Bone Inc(SIBN)Call | COM | 825704109 | $1.3M | 100,000 | 0.5% |
| Mannkind Corp(MNKD)Call | COM NEW | 56400P706 | $1.2M | 500,000 | 0.5% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $1.1M | 1,402,191 | 0.4% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $991.1K | 768,288 | 0.4% |
| In8bio Inc(INAB) | COM NEW | 45674E208 | $981.9K | 663,412 | 0.4% |
| Neumora Therapeutics Inc.(NMRA)Call | COM | 640979100 | $975.0K | 500,000 | 0.4% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $961.4K | 33,005 | 0.4% |
| Cytomx Therapeutics Inc.(CTMX)Call | COM | 23284F105 | $940.0K | 200,000 | 0.4% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $940.0K | 200,000 | 0.4% |
| Delcath SYS Inc(DCTH)Call | COM NEW | 24661P807 | $928.0K | 100,000 | 0.4% |
| Ardelyx Inc(ARDX)Call | COM | 039697107 | $898.5K | 150,000 | 0.4% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $878.0K | 708,102 | 0.4% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $874.5K | 50,000 | 0.4% |
| Connect Biopharma Hldgs LTD(CNTB) | SHS | G23549101 | $812.2K | 310,000 | 0.3% |
| Heron Therapeutics Inc(HRTX)Call | COM | 427746102 | $800.1K | 1,000,000 | 0.3% |
| Radiopharm Theranostics LTD | SPONSORED ADS | 75041J101 | $739.0K | 51,000,000 | 0.3% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $705.8K | 1,004,673 | 0.3% |
| Codexis Inc(CDXS) | COM | 192005106 | $681.3K | 417,994 | 0.3% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $657.5K | 597,682 | 0.3% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $643.5K | 134,060 | 0.3% |